Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc, together with its subsidiaries, develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market. The company is involved in the research, development, and production of kits for detection of immune reactions to food under the FoodPrint brand. It also provides clinical analysis to the general public, clinics, and heal… Read more
Cambridge Nutritional Sciences plc (CNSL) - Total Assets
Latest total assets as of September 2025: GBX12.69 Million GBX
Based on the latest financial reports, Cambridge Nutritional Sciences plc (CNSL) holds total assets worth GBX12.69 Million GBX as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Cambridge Nutritional Sciences plc - Total Assets Trend (2004–2025)
This chart illustrates how Cambridge Nutritional Sciences plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Cambridge Nutritional Sciences plc - Asset Composition Analysis
Current Asset Composition (March 2025)
Cambridge Nutritional Sciences plc's total assets of GBX12.69 Million consist of 55.5% current assets and 44.5% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 35.3% |
| Accounts Receivable | GBX1.77 Million | 12.8% |
| Inventory | GBX829.00K | 6.0% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX804.00K | 5.8% |
| Goodwill | GBX3.02 Million | 21.9% |
Asset Composition Trend (2004–2025)
This chart illustrates how Cambridge Nutritional Sciences plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cambridge Nutritional Sciences plc's current assets represent 55.5% of total assets in 2025, a decrease from 100.0% in 2004.
- Cash Position: Cash and equivalents constituted 35.3% of total assets in 2025, down from 100.0% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 26.0% of total assets, an increase from 0.0% in 2004.
- Asset Diversification: The largest asset category is goodwill at 21.9% of total assets.
Cambridge Nutritional Sciences plc Competitors by Total Assets
Key competitors of Cambridge Nutritional Sciences plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
OJsys Inc
PINK:OJSY
|
USA | $8.03 Million |
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
Cambridge Nutritional Sciences plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Cambridge Nutritional Sciences plc generates 0.60x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Cambridge Nutritional Sciences plc generates $ 11.35 in net profit.
Cambridge Nutritional Sciences plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.25 | 5.85 | 7.49 |
| Quick Ratio | 3.79 | 5.25 | 6.61 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX5.07 Million | GBX 6.22 Million | GBX 10.00 Million |
Cambridge Nutritional Sciences plc - Advanced Valuation Insights
This section examines the relationship between Cambridge Nutritional Sciences plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.43 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -0.7% |
| Total Assets | GBX13.80 Million |
| Market Capitalization | $579.03 USD |
Valuation Analysis
Below Book Valuation: The market values Cambridge Nutritional Sciences plc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Cambridge Nutritional Sciences plc's assets decreased by 0.7% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Cambridge Nutritional Sciences plc (2004–2025)
The table below shows the annual total assets of Cambridge Nutritional Sciences plc from 2004 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | GBX13.80 Million | -0.65% |
| 2024-03-31 | GBX13.89 Million | -3.55% |
| 2023-03-31 | GBX14.40 Million | -19.23% |
| 2022-03-31 | GBX17.84 Million | -39.64% |
| 2021-03-31 | GBX29.55 Million | +56.86% |
| 2020-03-31 | GBX18.84 Million | -19.76% |
| 2019-03-31 | GBX23.48 Million | +2.50% |
| 2018-03-31 | GBX22.90 Million | -11.09% |
| 2017-03-31 | GBX25.76 Million | +8.33% |
| 2016-03-31 | GBX23.78 Million | +5.03% |
| 2015-03-31 | GBX22.64 Million | +2.95% |
| 2014-03-31 | GBX21.99 Million | +24.89% |
| 2013-03-31 | GBX17.61 Million | +5.37% |
| 2012-03-31 | GBX16.71 Million | -3.97% |
| 2011-03-31 | GBX17.40 Million | +90.17% |
| 2010-03-31 | GBX9.15 Million | +10.76% |
| 2009-03-31 | GBX8.26 Million | +2.53% |
| 2008-03-31 | GBX8.06 Million | +359.77% |
| 2007-03-31 | GBX1.75 Million | +1052.89% |
| 2005-12-31 | GBX152.00K | -31.84% |
| 2004-12-31 | GBX223.00K | -- |